TK
Towa Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Generic Drug Portfolio | Various Therapeutic Areas | Approved |
| ANDA Pipeline Candidates | Various (e.g., Antibiotics, Antihypertensives) | Regulatory Review |
| Biosimilar Development Programs | Inflammatory Diseases, Oncology | Research |
Leadership Team at Towa Pharmaceutical
YK
Yoshihiro Kawaguchi
Representative Director and President (CEO)
KN
Kazuhiko Nakatani
Director and Senior Managing Executive Officer
HO
Hiroshi Okamoto
Director and Managing Executive Officer
YN
Yasuhiro Nakai
Director and Managing Executive Officer
TT
Tetsuo Takeuchi
Director
YI
Yoshinori Ikeda
Director
KS
Kunihiko Sasaki
Director
MG
Masahiko Gemma
Outside Director
YK
Yoshiko Kito
Outside Director
HM
Hiroshi Matsumura
Standing Corporate Auditor